News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nutra Pharma Corp. (NPHC)'s Subsidary Designer Diagnostics Inc. Engages U.S. Commercial Service for International Growth



3/1/2007 12:45:06 PM

BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its medical device subsidiary, Designer Diagnostics, has initiated a partnership with the U.S. Commercial Service to help build international sales of its diagnostic test kits.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES